Anthony Digiandomenico, Director at Provention Bio, Inc. (PRVB), bought 30,000 shares at $6.83 ($205K) on 2019-09-30, disclosed to the SEC on 2019-09-30.
Open-market purchase of $205k PRVB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| MDBH | BUY | 2025-02-14 | $8K | — | Filing → |
| MDBH | BUY | 2025-02-11 | $12K | — | Filing → |
| MDBH | BUY | 2025-02-06 | $4K | — | Filing → |